Company / Operating Cash Flow per Share
Praxis Precision Medicines, Inc. Operating Cash Flow per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$12.82
FY2025
5-year range
-$60.21 / -$2.93
FY2021-FY2025
Trend
+14.4%
vs FY2024
Sector context
#207 of 212
Health Care
What the data says
Among 212 Health Care companies, Praxis Precision Medicines, Inc. is in the bottom 2% for operating cash flow per share. Operating Cash Flow per Share has increased for 3 consecutive years, from $-60.21 in FY2022 to $-12.82 in FY2025.
Based on SEC 10-K filings.
-12.82 in FY2025.
Improved from $-33.76 to $-12.82 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 2% in Health CareTop 98% of 212This company -$12.82 Sector average -$14.72
▼
+12.9% above sector average
Key checks
Key Insights
- Praxis Precision Medicines, Inc.'s operating cash flow per share has grown for 3 consecutive years.
- In FY2025, operating cash flow per share increased 14.4% year-over-year.
- Ranks #207 out of 212 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 4.48 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$12.82 | +14.4% |
| FY2024 | -$14.99 | +55.6% |
| FY2023 | -$33.76 | +43.9% |
| FY2022 | -$60.21 | -1952.4% |
| FY2021 | -$2.93 | +50.1% |
| FY2020 | -$5.88 | +73.1% |
| FY2019 | -$21.85 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026